RecruitingNCT07388628
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
ARTISTRY - ARTICE® Therapy Registry Study
Sponsor
Artcline GmbH
Enrollment
200 participants
Start Date
Sep 25, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07388628
Related Trials
Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?
NCT035474141 location
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT0717927628 locations
TIMP2*IGFBP7 and Transient AKI
NCT034720791 location
ICU Combined Assessment of Cardio-Respiratory Exercise
NCT061939802 locations
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT0685464020 locations